Evidence for professionals
Evidence and information to support and inform your work.
Download our evidence pack with everything you need to know about prescribing Sativex, including cost effectiveness and case studies.
You can also read our 'Approved but Denied' policy report that looks at access to Sativex to treat MS related spasticity in England.
If you'd like to find out more, we partnered with MS Academy to run a webinar on prescribing Sativex for spasticity in MS:
Our Neurology now report looks at access to neurology services in the UK, and makes the case for a new approach.